Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection.
about
A Practical Approach to Management of Chronic Hepatitis BManagement of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelinesManagement of chronic hepatitis B in pregnancyManagement of chronic hepatitis B virus infection: current perspectives for the nurse practitioner.Vertical transmission of hepatitis B virus: challenges and solutionsAntiviral therapy and resistance with hepatitis B virus infection.Hepatitis B Virus Infection during Pregnancy: Transmission and Prevention.Hepatitis B Therapy in PregnancyEvaluation and management of hepatitis B in pregnancy: a survey of current practicesSafety of tenofovir during pregnancy for the mother and fetus: a systematic review.The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis.Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study.Breastfeeding is not a risk factor for mother-to-child transmission of hepatitis B virus.Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitals.Prevention of hepatitis B.Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials.Emerging drugs for hepatitis B.HBeAg negative serological status and low viral replication levels characterize chronic hepatitis B virus-infected women at reproductive age in Greece: a one-year prospective single center study.A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virusChronic hepatitis B infection in pregnancyEfficacy and safety of nucleoside analogs on blocking father-to-infant vertical transmission of hepatitis B virus.Chronic hepatitis B in pregnancy: unique challenges and opportunitiesEpidemiology of Hepatitis B Virus Infection in China: Current Status and ChallengesHepatitis B mother--to--child transmission.Lamivudine for chronic hepatitis B.Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is PregnantConstruction of exogenous multiple epitopes of helper T lymphocytes and DNA immunization of its chimeric plasmid with HBV pre-S2/S gene.Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update.24 year outcomes of hepatitis B vaccination in Hangzhou, China.Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy.Chronic HBV infection among pregnant women and their infants in Shenyang, ChinaHepatitis B and C in pregnancy: a review and recommendations for care.Case treated with triple therapy of lamivudine, interferon-β and prednisolone for acute exacerbation of chronic hepatitis B during pregnancyManagement of chronic hepatitis B: consensus guidelinesTowards the elimination and eradication of hepatitis B.Management of hepatic complications in HIV-infected persons.Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategiesTelbivudine treatment of hepatitis B virus-infected pregnant women at different gestational stages for the prevention of mother-to-child transmission: Outcomes of telbivudine treatment during pregnancy.Chronic hepatitis B in Asian women of childbearing age.Hepatobiliary diseases during pregnancy and their management: An update
P2860
Q24810145-80C1A60A-CB35-4712-A8F0-04EE6D964716Q27000080-7CFFAC90-FF98-4BF9-9242-3DC24A441225Q27026593-334813C9-3A7F-4AE4-A468-43673016672BQ33242705-CD631FE6-2972-44D8-ABFC-34388D0D9D19Q33774099-32C32149-51E3-42A8-ABAF-D15C90E83D07Q33787531-80DAF57E-AEB2-453E-A188-67AF82B130B5Q34135030-F83CB38F-6DB1-4E60-8E90-62912DFB3DF1Q34154952-9EF9C0AA-51EA-432E-9781-801643F41CFEQ34293333-F0E2BC7D-97B3-434C-8B06-FB3231714E63Q34371989-A57BC46B-0A57-4D09-BE8D-1AA1684CF43EQ34402956-498B0119-7880-46DC-A6F0-92146CA85860Q34524575-C55BE01F-F618-4279-8F2F-8399239C4763Q34576359-630BBF64-7BBC-4CE7-92D3-5DCFDB2FE919Q35056461-E084BDDF-A095-4877-B229-EDDEDE18A5BCQ35164249-D348FC10-E6FD-4657-8A09-ECF33F6076F6Q35196581-8D9CB1EE-28F9-4FAD-A47D-D7911689E699Q35359369-2A613C38-ACF1-45DC-8469-166AB8A02102Q35435831-E6CC6F50-7CA5-4FDB-BAA5-2DEBAD4C875CQ35545742-30CAA155-0114-4A1C-B5B5-561C8B6BD930Q35626775-DF4D4772-52FD-4507-B56A-87519EFDEB85Q35758063-33BD12C7-E712-4265-88F3-C70FAC9992F0Q35833069-9EC68535-6886-4633-A7AC-7FFE1484B978Q35905968-BA85775B-4B0A-4B03-B539-0BE9BE0E6EBAQ35917346-B14EFC38-193D-4F53-963B-E1653CD06411Q35917357-5F664BC6-8621-42B6-B959-F9F6DD5AEE07Q35999165-4903978F-62CE-4B15-BDF7-036201F65B80Q36076440-05B7E2BB-DE68-41A9-AC36-79FE1BD9CDDFQ36135493-97742CA1-6468-4741-93DB-65E6B337DE9EQ36256369-2A56C44A-290C-465F-89E5-C2B1FCD84F50Q36502571-4A408963-F7C3-40ED-B1B6-C63AAD3D3FABQ36597302-4A0B73D7-C5F2-4C29-8FEF-DF9BFFF0B0F2Q36649138-B5B696BD-C5A1-4F2F-B019-5BD35FC7F2ADQ36801132-6C35BC8A-C35E-43FD-B19D-98DEEF5537D3Q36849343-65A8227C-C2E8-4811-98F9-4B9D69DC8250Q37098214-F953DD95-F4DA-4D35-A15C-587B9150BA47Q37151303-2D2DC324-2A17-4A5E-B81C-D9C175724000Q37278061-C9DD7E64-19B5-419B-87F2-980FD1AD17D6Q37328793-CB51D213-62C8-4487-BBB1-2131010DF8D0Q37380063-8DF6B5FA-6D43-45CB-9CD5-4F9B5D6735B5Q37443165-23FB0573-2A48-4C71-8DB7-7F4DF8014DFC
P2860
Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Lamivudine treatment during pr ...... f hepatitis B virus infection.
@en
Lamivudine treatment during pr ...... f hepatitis B virus infection.
@nl
type
label
Lamivudine treatment during pr ...... f hepatitis B virus infection.
@en
Lamivudine treatment during pr ...... f hepatitis B virus infection.
@nl
prefLabel
Lamivudine treatment during pr ...... f hepatitis B virus infection.
@en
Lamivudine treatment during pr ...... f hepatitis B virus infection.
@nl
P2093
P2860
P1476
Lamivudine treatment during pr ...... f hepatitis B virus infection.
@en
P2093
Janssen HL
van Nunen AB
van Zonneveld M
P2860
P304
P356
10.1046/J.1365-2893.2003.00440.X
P577
2003-07-01T00:00:00Z